The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Taiho Pharmaceutical
Prognostic Significance of Immunohistochemical Mapping of Six Steroid Receptors (SR) in Non Small Cell Lung Cancer (NSCLC). Final Analysis in 248 Cases.
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hiroaki Nozawa
No Relationships to Disclose
 
Takako Eguchi Nakajima
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Dainippon Sumitomo Pharma; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly Japan; MERCK SERONO; Ono Pharmaceutical; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Amgen Astellas BioPharma; AstraZeneca; Chugai Pharma; Dainippon Sumitomo Pharma; Eisai; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; MSD K.K; Ono Pharmaceutical; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hiroya Taniguchi
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Boehringer Ingelheim (Inst); MSD Oncology (Inst); Otsuka (Inst); Takeda (Inst)
 
Satoshi Morita
Honoraria - Chugai Pharma; Daiichi Sankyo; Taiho Pharmaceutical
 
Naruhito Takenaka
Employment - Taiho Pharmaceutical
Stock and Other Ownership Interests - Otsuka
 
Daisuke Ozawa
Employment - Taiho Pharmaceutical
Stock and Other Ownership Interests - Otsuka
 
Kuniaki Shirao
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical